These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22076637)

  • 1. The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.
    Soulez M; Pilon EA; Dieudé M; Cardinal H; Brassard N; Qi S; Wu SJ; Durocher Y; Madore F; Perreault C; Hébert MJ
    Circ Res; 2012 Jan; 110(1):94-104. PubMed ID: 22076637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.
    Cardinal H; Dieudé M; Brassard N; Qi S; Patey N; Soulez M; Beillevaire D; Echeverry F; Daniel C; Durocher Y; Madore F; Hébert MJ
    Am J Transplant; 2013 Apr; 13(4):861-874. PubMed ID: 23432943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perlecan fragment LG3 regulates homing of mesenchymal stem cells and neointima formation during vascular rejection.
    Pilon EA; Dieudé M; Qi S; Hamelin K; Pomerleau L; Beillevaire D; Durocher Y; Zutter M; Coutu D; Perreault C; Hébert MJ
    Am J Transplant; 2015 May; 15(5):1205-18. PubMed ID: 25808553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells.
    Soulez M; Sirois I; Brassard N; Raymond MA; Nicodème F; Noiseux N; Durocher Y; Pshezhetsky AV; Hébert MJ
    Stem Cells; 2010 Apr; 28(4):810-20. PubMed ID: 20201065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection.
    Dieudé M; Bell C; Turgeon J; Beillevaire D; Pomerleau L; Yang B; Hamelin K; Qi S; Pallet N; Béland C; Dhahri W; Cailhier JF; Rousseau M; Duchez AC; Lévesque T; Lau A; Rondeau C; Gingras D; Muruve D; Rivard A; Cardinal H; Perreault C; Desjardins M; Boilard É; Thibault P; Hébert MJ
    Sci Transl Med; 2015 Dec; 7(318):318ra200. PubMed ID: 26676607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.
    Grimm PC; Nickerson P; Jeffery J; Savani RC; Gough J; McKenna RM; Stern E; Rush DN
    N Engl J Med; 2001 Jul; 345(2):93-7. PubMed ID: 11450677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
    Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC.
    Raymond MA; Désormeaux A; Laplante P; Vigneault N; Filep JG; Landry K; Pshezhetsky AV; Hébert MJ
    FASEB J; 2004 Apr; 18(6):705-7. PubMed ID: 14977881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
    Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
    Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase.
    Sivritas D; Becher MU; Ebrahimian T; Arfa O; Rapp S; Bohner A; Mueller CF; Umemura T; Wassmann S; Nickenig G; Wassmann K
    Basic Res Cardiol; 2011 Jun; 106(4):563-75. PubMed ID: 21484412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated neointimal endothelin-1 in transplantation-associated arteriosclerosis of renal allograft recipients.
    Simonson MS; Emancipator SN; Knauss T; Hricik DE
    Kidney Int; 1998 Sep; 54(3):960-71. PubMed ID: 9734624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice.
    Li J; Han X; Jiang J; Zhong R; Williams GM; Pickering JG; Chow LH
    Am J Pathol; 2001 Jun; 158(6):1943-7. PubMed ID: 11395369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor and recipient contribution to transplant vasculopathy in chronic renal transplant dysfunction.
    Boersema M; Rienstra H; van den Heuvel M; van Goor H; van Luyn MJ; Navis GJ; Popa ER; Hillebrands JL
    Transplantation; 2009 Dec; 88(12):1386-92. PubMed ID: 20029335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated numbers of circulating endothelial cells in renal transplant recipients.
    Woywodt A; Schroeder M; Gwinner W; Mengel M; Jaeger M; Schwarz A; Haller H; Haubitz M
    Transplantation; 2003 Jul; 76(1):1-4. PubMed ID: 12865778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.